It is worthy of note that these studies do not directly inform on the activation state of the complement pathway, and indeed in our study we see upgregulation of SerpinG1, which inhibits complement C4 cleavage by C1 and MASP2, as well as increased levels of C4, C3 and various regulators in AD. Here, C4A is linked to Alzheimer disease.